Pulmonary Disorders I
Med.
2015;43(2):288-295.
https://doi.org/10.1097/
ccm.0000000000000715
Guérin C, Reignier J, Richard JC, et al. Prone position-
ing in severe acute respiratory distress syndrome. N Engl
J Med. 2013;368(23):2159-2168. https://doi.org/10.1056/
nejmoa1214103
Hu SL, He HL, Pan C, et al. The effect of prone posi-
tioning on mortality in patients with acute respiratory
distress syndrome: a meta-analysis of randomized con-
org/10.1186/cc13896
Lee JM, Bae W, Lee YJ, Cho YJ. The efficacy
and safety of prone positional ventilation in acute
respiratory distress syndrome: updated study-level meta-
Med.
2014;42(5):1252-1262.
https://doi.org/10.1097/
ccm.0000000000000122
Meduri GU, Headley AS, Golden E, et al. Effect of
prolonged methylprednisolone therapy in unresolv-
ing acute respiratory distress syndrome: a randomized
org/10.1001/jama.280.2.159
Munshi L, Del Sorbo L, Adhikari NKJ, et al. Prone
position for acute respiratory distress syndrome. a sys-
2017;14(suppl_4):S280-S288.
https://doi.org/10.1513/
annalsats.201704-343ot
National Heart, Lung, and Blood Institute Acute
Respiratory Distress Syndrome (ARDS) Clinical Trials
Network; Wiedemann HP, Wheeler AP, Bernard GR, et
al. Comparison of two fluid-management strategies in
acute lung injury. N Engl J Med. 2006;354(24):2564-
2575. https://doi.org/10.1056/nejmoa062200
National Heart, Lung, and Blood Institute PETAL Clinical
Trials Network; Moss M, Huang DT, Brower RG, et al.
Early neuromuscular blockade in the acute respiratory
distress syndrome. N Engl J Med. 2019;380(21):1997-
2008. https://doi.org/10.1056/nejmoa1901686
National Institutes of Health; COVID-19 Treatment
Guidelines Panel. Coronavirus Disease 2019 (COVID-
19) Treatment Guidelines.
Papazian L, Aubron C, Brochard L, et al. Formal
guidelines: management of acute respiratory distress
org/10.1186/s13613-019-0540-9
Papazian L, Forel JM, Gacouin A, et al. Neuromuscular
blockers in early acute respiratory distress syndrome.
N Engl J Med. 2010;363(12):1107-1116. https://doi.
org/10.1056/nejmoa1005372
Papazian L, Schmidt M, Hajage D, et al. Effect of prone
positioning on survival in adult patients receiving veno-
venous extracorporeal membrane oxygenation for acute
respiratory distress syndrome: a systematic review and
https://doi.org/10.1007/s00134-021-06604-x
Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy
and economic assessment of conventional venti-
latory
support
versus
extracorporeal
membrane
oxygenation for severe adult respiratory failure (CESAR):
2009;374(9698):
1351-1363.
https://doi.org/10.1016/
s0140-6736(09)61069-2
Qadir N, Sahetya S, Munshi L, et al. An update on
management of adult patients with acute respiratory
distress syndrome: an official American Thoracic
rccm.202311-2011st
RECOVERY Collaborative Group; Horby P, Lim WS,
Emberson JR, et al. Dexamethasone in hospitalized
patients with Covid-19. N Engl J Med. 2021;384(8):693-
704. https://doi.org/10.1056/nejmoa2021436
Schmidt M, Bailey M, Sheldrake J, et al. Predicting
survival after extracorporeal membrane oxygenation
for severe acute respiratory failure. The Respiratory
Extracorporeal
Membrane
Oxygenation
Survival
Med. 2014;189(11):1374-1382. https://doi.org/10.1164/
rccm.201311-2023oc
Scholten EL, Beitler JR, Prisk GK, Malhotra A. Treatment
of ARDS with prone positioning. Chest. 2017;151(1):215-
224. https://doi.org/10.1016/j.chest.2016.06.032
Silversides JA, Major E, Ferguson AJ, et al. Conservative
fluid management or deresuscitation for patients with sep-
sis or acute respiratory distress syndrome following the
resuscitation phase of critical illness: a systematic review
170. https://doi.org/10.1007/s00134-016-4573-3
Silversides JA, McMullan R, Emerson LM, et al.
Feasibility of conservative fluid administration and
deresuscitation compared with usual care in critical